Salt water after clot-busting treatment for stroke
Part of Brain & nervous system, Heart & circulation clinical trials.
This study tests if giving a simple saline (salt water) drip after the standard clot-busting medicine helps improve recovery in people who had a stroke from a clot. It may be a safe, low-cost way to support brain healing.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be between 18 and 80 years old.
- You must have had a stroke caused by a clot and received a clot-busting medicine within 4.5 hours of symptoms starting (or within a certain time window if onset time is unknown).
- You must not have had significant disability before your stroke.
- You must not have a history of heart failure, irregular heartbeat (atrial fibrillation), or serious kidney problems.
- You must not have had any severe bleeding episodes recently or any condition that prevents the use of the clot-busting medicine.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether giving a medicine called Cerebrolysin after a delayed procedure to remove a blood clot from the brain can help people recover from a severe stroke. It looks at people who have their clot removed more than 6 hours after symptoms start.
This trial tests if a clot-dissolving medicine can help people who had a mild ischemic stroke and also had a prior stroke in the last 3 months. It aims to see if the treatment is safe and effective for this specific group.
This trial tests whether a clot-busting drug given directly into the brain artery can improve recovery after a major stroke caused by a blockage in the front part of the brain. The study is for people whose blood flow has already been successfully restored with standard treatments.
This study looks at how much water builds up in brain tissue after a stroke is treated with a clot-busting drug. It may help doctors understand who will recover better.
This trial tests whether giving a clot-busting drug (alteplase) within 4.5 hours helps people who have a mild stroke with symptoms like vision problems, facial drooping, or trouble speaking, but no weakness in an arm or leg.
This trial tests if giving a clot-busting drug (tenecteplase) directly into the brain artery after a successful clot-removal procedure can improve outcomes for people with a major stroke. It is for patients who had a large vessel blockage and received endovascular thrombectomy within 24 hours of symptoms starting.
Hear when a new Brain Infarction trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.